Our community offers innovative founders the opportunity to access equitable investment for their impact-driven company.
We’re ensuring we do our part to bridge the early investment gap by providing our investor members the key educational resources necessary to invest with purpose.
Our accredited investor members have the opportunity to invest in companies that pitch to Spring Collective. We offer ongoing deal screenings where entrepreneurs pitch their impact businesses. For these deal screenings we’re seeking companies that are:
In addition to funding for selected companies, Spring Collective can also provide resources, mentorship and networking opportunities to support you in leveraging our investment. Everyone is welcome, but we recognize the systemic underfunding of companies with leadership from equity-deserving groups and will prioritize these companies for deal screenings.
This innovative, women-led company is revolutionizing the colour industry with sustainable dyes. They use microorganisms in a circular system to ensure people + planet are safe.
I am thrilled that my company, Vessl, is part of Spring Collective’s deal flow. Several folks have reached out directly to express their willingness to provide direct feedback and guidance in their area of specialization, which will help move my company forward.
Sydney Robinson
CEO & Co-Founder, Vessl Prosthetics
Through our programs, private-deal screenings, and pooled-investment opportunities the investor ecosystem at Spring has driven capital into 47 companies since its inception in 2019. Nine of these companies have been selected for investment from Spring Collective. These are the game-changing companies we’ve invested in to date.
Acuicy is business intelligence software for net-zero supply chains.
We make it easy to engage and incentivize suppliers to cut emissions at source. Acuicy uses deep data and AI to give tailored business intelligence with financial ROI to help businesses make decisions faster and cut operating costs while reducing emissions. Enterprise customers get reliable primary data to track progress on their net-zero targets in real time at a fraction of the cost of current solutions.
Creating 3D vascularized cancer tissue models for the drug development industry and oncology research.
Our 3D Bioprinter uses a state of the art laser with a process that crosslinks bioink with extreme precision, producing incredible high resolution 3D bioprinted tissues. Combined with our proprietary software, we are able to print tissues with vasculature for more meaningful in vitro testing. This process occurs only at the focal point of the laser (the voxel, hence VoxCell), allowing for printing anywhere in the polymer, including within structures, unlike traditional extrusion based 3D bioprinters.
A B2B software and services platform that accelerates the delivery of smart and connected services to society.
The Asset Market solution connects Asset Owners and Service Providers through a digital platform with high quality data and analytics, making the installation of wireless sites, EV charging infrastructure and IOT devices faster, cheaper and easier to scale.
Sustainable, plant-based seafood made from wholesome ingredients.
Imagine a world where we no longer need to kill fish to enjoy seafood. Our sustainable, plant-based seafood is made from wholesome ingredients and convincingly mimics the taste and texture, allowing each of us to do our small part to help reduce our environmental impact.
Upcycling organic waste into precise, pathogen free liquid fertilizer.
Aya is a leading Canadian health technology company revolutionizing the way individuals manage their healthcare expenses since 2018.
Aya is a leading Canadian health technology company revolutionizing the way individuals manage their healthcare expenses since 2018. With the Aya card, employees don’t have to pay medical costs upfront. The HSA is like a personalized bank account for medical, dental, and vision expenses.
Vessl is pioneering novel prosthetics for amputees, led by biomedical engineers, clinical anatomists, and prosthetists.
Founder: Sydney Robinson
SDGs:
Sector: Health
Stage: Pre-Seed
The first product, isoform, is an automatically adjusting socket that empowers amputees through improved comfort.
By harnessing the incredible power of biology, we are ushering in a new era of sustainable, high-performance color.
By harnessing the incredible power of biology, we are ushering in a new era of sustainable, high-performance color.Our innovative colours are grown by living microorganisms in resulting in hues that are both stunning and eco-friendly.
MIMOSA Diagnostics Inc. is a leading provider of intuitive, equitable, and accessible healthcare technology.
Their flagship product, the MIMOSA Pro is a pocket-sized imaging device that streamlines tissue health assessments for clinicians by capturing temperature, tissue oxygenation, and digital images in less than one second. The images are then uploaded to a HIPAA-compliant web portal where clinicians can monitor patient progress, identify early opportunities for intervention, and collaborate towards improved patient outcomes.
It’s beyond time for women and non-binary founders to get equitable access to investment for their startups. Let’s change the landscape together.
Learn More
Are you a fit for collective investment?
If you’re a Canadian or American impact entrepreneur seeking pre-seed, seed or intermediate financing we want to hear from you.
apply nowInvestment readiness training to support your growth as an impact-based founder.
Visit SpringOur impact fund investing in early-stage Canadian founders, catalyzing scalability and meaningful impact.
Visit Spring Impact Capital